FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2619026215> ?p ?o ?g. }

• W2619026215 abstract "Renal cell carcinoma (RCC) is a tumor with immunogenic properties. Soluble interleukin-2 receptor (sIL-2R) has a role in T cell activation and may be important for immune regulation in various conditions, including infections, transplantation rejection, autoimmune inflammatory states, and cancer. We investigated the prognostic value of the serum sIL-2R level in patients with metastatic RCC receiving IFN-alpha and vascular endothelial growth factor (VEGF)-targeting therapy. We monitored the serum level of sIL-2R over time and examined phosphorylated Akt expression by the primary tumor in 47 patients with metastatic clear cell RCC (ccRCC) undergoing cytoreductive nephrectomy followed by first-line adjuvant therapy with IFN-alpha plus sequential VEGF-targeting therapy as second- or third-line adjuvant therapy. A preoperative increase of the serum level of sIL-2R was correlated with a higher preoperative serum level of programmed cell death 1 (PD-1)-ligand 1 (PD-L1), increased expression of phosphorylated Akt by the primary tumor, and a worse response to IFN-alpha/sequential VEGF-targeting therapy, as well as being an independent prognostic factor for a shorter overall survival time by multivariate analysis. Over time, the serum sIL-2R level largely reflected the tumor response to therapy. Monitoring the serum level of sIL-2R may help to predict the biological behavior of ccRCC, its response to IFN-alpha/sequential VEGF-targeting therapy, and the prognosis." @default.
• W2619026215 created "2017-06-05" @default.
• W2619026215 creator A5000874948 @default.
• W2619026215 creator A5005428468 @default.
• W2619026215 creator A5016160132 @default.
• W2619026215 creator A5036058432 @default.
• W2619026215 creator A5056599457 @default.
• W2619026215 creator A5070395387 @default.
• W2619026215 date "2017-05-25" @default.
• W2619026215 modified "2023-09-26" @default.
• W2619026215 title "Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy" @default.
• W2619026215 cites W1516226356 @default.
• W2619026215 cites W1527381664 @default.
• W2619026215 cites W1953996694 @default.
• W2619026215 cites W1972186730 @default.
• W2619026215 cites W1974313653 @default.
• W2619026215 cites W1987755269 @default.
• W2619026215 cites W1999193852 @default.
• W2619026215 cites W2004150448 @default.
• W2619026215 cites W2004630197 @default.
• W2619026215 cites W2009644403 @default.
• W2619026215 cites W2010715204 @default.
• W2619026215 cites W2013084027 @default.
• W2619026215 cites W2016732129 @default.
• W2619026215 cites W2041698974 @default.
• W2619026215 cites W2049345643 @default.
• W2619026215 cites W2058648826 @default.
• W2619026215 cites W2100039832 @default.
• W2619026215 cites W2101549029 @default.
• W2619026215 cites W2112278221 @default.
• W2619026215 cites W2112601576 @default.
• W2619026215 cites W2117692326 @default.
• W2619026215 cites W2121356249 @default.
• W2619026215 cites W2138163780 @default.
• W2619026215 cites W2139248078 @default.
• W2619026215 cites W2139276825 @default.
• W2619026215 cites W2142583550 @default.
• W2619026215 cites W2146530991 @default.
• W2619026215 cites W2148226248 @default.
• W2619026215 cites W2149246783 @default.
• W2619026215 cites W2160551785 @default.
• W2619026215 cites W2199205868 @default.
• W2619026215 cites W4249590246 @default.
• W2619026215 doi "https://doi.org/10.1186/s12885-017-3369-3" @default.
• W2619026215 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5445282" @default.
• W2619026215 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28545581" @default.
• W2619026215 hasPublicationYear "2017" @default.
• W2619026215 type Work @default.
• W2619026215 sameAs 2619026215 @default.
• W2619026215 citedByCount "19" @default.
• W2619026215 countsByYear W26190262152017 @default.
• W2619026215 countsByYear W26190262152019 @default.
• W2619026215 countsByYear W26190262152020 @default.
• W2619026215 countsByYear W26190262152021 @default.
• W2619026215 countsByYear W26190262152022 @default.
• W2619026215 countsByYear W26190262152023 @default.
• W2619026215 crossrefType "journal-article" @default.
• W2619026215 hasAuthorship W2619026215A5000874948 @default.
• W2619026215 hasAuthorship W2619026215A5005428468 @default.
• W2619026215 hasAuthorship W2619026215A5016160132 @default.
• W2619026215 hasAuthorship W2619026215A5036058432 @default.
• W2619026215 hasAuthorship W2619026215A5056599457 @default.
• W2619026215 hasAuthorship W2619026215A5070395387 @default.
• W2619026215 hasBestOaLocation W26190262151 @default.
• W2619026215 hasConcept C121608353 @default.
• W2619026215 hasConcept C126322002 @default.
• W2619026215 hasConcept C143998085 @default.
• W2619026215 hasConcept C167734588 @default.
• W2619026215 hasConcept C203014093 @default.
• W2619026215 hasConcept C2776178377 @default.
• W2619026215 hasConcept C2777025900 @default.
• W2619026215 hasConcept C2777472916 @default.
• W2619026215 hasConcept C2777982462 @default.
• W2619026215 hasConcept C2781230642 @default.
• W2619026215 hasConcept C2909179924 @default.
• W2619026215 hasConcept C502942594 @default.
• W2619026215 hasConcept C71924100 @default.
• W2619026215 hasConceptScore W2619026215C121608353 @default.
• W2619026215 hasConceptScore W2619026215C126322002 @default.
• W2619026215 hasConceptScore W2619026215C143998085 @default.
• W2619026215 hasConceptScore W2619026215C167734588 @default.
• W2619026215 hasConceptScore W2619026215C203014093 @default.
• W2619026215 hasConceptScore W2619026215C2776178377 @default.
• W2619026215 hasConceptScore W2619026215C2777025900 @default.
• W2619026215 hasConceptScore W2619026215C2777472916 @default.
• W2619026215 hasConceptScore W2619026215C2777982462 @default.
• W2619026215 hasConceptScore W2619026215C2781230642 @default.
• W2619026215 hasConceptScore W2619026215C2909179924 @default.
• W2619026215 hasConceptScore W2619026215C502942594 @default.
• W2619026215 hasConceptScore W2619026215C71924100 @default.
• W2619026215 hasIssue "1" @default.
• W2619026215 hasLocation W26190262151 @default.
• W2619026215 hasLocation W26190262152 @default.
• W2619026215 hasLocation W26190262153 @default.
• W2619026215 hasLocation W26190262154 @default.
• W2619026215 hasOpenAccess W2619026215 @default.
• W2619026215 hasPrimaryLocation W26190262151 @default.
• W2619026215 hasRelatedWork W1995490256 @default.
• W2619026215 hasRelatedWork W2018137790 @default.
• W2619026215 hasRelatedWork W2038260901 @default.

• next